Description
THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P
Technology
Stats
- 26,567 US PATENTS IN FORCE
- 50,272 US APPLICATIONS PENDING
- 15,724 Total Patent Owners
- 223,619 TOTAL INVENTORS
Subclasses
| Subclass | Title |
|---|---|
| 1/00 | Drugs for disorders of the alimentary tract or the digestive system |
| 1/02 | Drugs for disorders of the alimentary tract or the digestive system Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis |
| 1/04 | Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants |
| 1/06 | Drugs for disorders of the alimentary tract or the digestive system Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia |
| 1/08 | Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics |
| 1/10 | Drugs for disorders of the alimentary tract or the digestive system Laxatives |
| 1/12 | Drugs for disorders of the alimentary tract or the digestive system Antidiarrhoeals |
| 1/14 | Drugs for disorders of the alimentary tract or the digestive system Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents |
| 1/16 | Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics |
| 1/18 | Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes |
| 3/00 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) |
| 3/02 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Nutrients, e.g. vitamins, minerals |
| 3/04 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Anorexiants; Antiobesity agents |
| 3/06 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics |
| 3/08 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) |
| 3/10 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for glucose homeostasis (pancreatic hormones A61P 5/48) for hyperglycaemia, e.g. antidiabetics |
| 3/12 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis |
| 3/14 | Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) for electrolyte homeostasis for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/1; bone metastasis A61P 35/04) |
| 5/00 | Drugs for disorders of the endocrine system |
| 5/02 | Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin |
Recent Patents
Not Available
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0306,670 | BERBERINE ALKALOIDS IN THE PREVENTION AND/OR TREATMENT OF INTESTINAL DISEASE | Apr 25, 24 | Sep 19, 24 | Not available |
| 2024/0307,292 | SCALP MICROBIOME COMPLEX AND USE THEREOF FOR IMPROVING HAIR OR SCALP CONDITION | Sep 06, 22 | Sep 19, 24 | COSMAX, INC. |
| 2024/0307,295 | METHODS FOR TREATING GOUT AND BONE DECALCIFICATION | May 21, 24 | Sep 19, 24 | Not available |
| 2024/0307,296 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | Jan 29, 24 | Sep 19, 24 | BIOCORRX PHARMACEUTICALS, INC. |
| 2024/0307,301 | CHEWABLE PHARMACEUTICAL PRODUCT FOR DELIVERY OF COLESEVELAM HYDROCHLORIDE | May 20, 24 | Sep 19, 24 | Not available |
| 2024/0307,305 | ATROPINE-CONTAINING AQUEOUS COMPOSITION | May 28, 24 | Sep 19, 24 | Not available |
| 2024/0307,316 | ANTIOXIDANT AND OXYGEN-RELEASING LIGNIN COMPOSITES TO ACCELERATE WOUND HEALING | Mar 15, 24 | Sep 19, 24 | Not available |
| 2024/0307,318 | COMPOSITIONS AND USES THEREOF IN TREATING CANCERS | Mar 17, 23 | Sep 19, 24 | National Cheng Kung University |
| 2024/0307,321 | NANO-PARTICLES OF MENAQUINONE AND METHODS OF TREATMENT | Feb 20, 24 | Sep 19, 24 | Epizon Pharma, Inc. |
| 2024/0307,325 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING OR AMELIORATING NONALCOHOLIC FATTY LIVER DISEASE AND RELATED DISEASES OR DISORDERS | Jan 14, 22 | Sep 19, 24 | Not available |
| 2024/0307,328 | MIRDAMETINIB TREATMENT | May 24, 24 | Sep 19, 24 | Not available |
| 2024/0307,329 | MIRDAMETINIB TREATMENT | May 24, 24 | Sep 19, 24 | Not available |
| 2024/0307,330 | MIRDAMETINIB TREATMENT | May 24, 24 | Sep 19, 24 | Not available |
| 2024/0307,331 | COMPOUNDS FOR PREVENTION AND TREATMENT OF HEMORRHAGE AND VASCULATURE INSTABILITY | Aug 23, 21 | Sep 19, 24 | Not available |
| 2024/0307,334 | USE OF SOBETIROME AND PRODRUGS AND DERIVATIVES THEREOF FOR TREATING PITT-HOPKINS SYNDROME | Jan 09, 24 | Sep 19, 24 | Not available |
| 2024/0307,337 | Method Of Treatment Of Obesity | May 29, 24 | Sep 19, 24 | Not available |
| 2024/0307,338 | USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHLOROGENIC ACID IN PREPARATION OF MEDICAMENT FOR TREATING PATHOLOGIC JAUNDICE | Jan 13, 21 | Sep 19, 24 | Not available |
| 2024/0307,339 | NOVEL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF NEUROLOGICAL COMPLICATIONS OF VIRAL INFECTIONS | Jun 17, 22 | Sep 19, 24 | Not available |
| 2024/0307,340 | IMMUNOSUPPRESSIVE PHARMACEUTICAL COMPOSITION INCLUDING BENZENE DERIVATIVE AS IMMUNOSUPPRESSANT | Jan 19, 22 | Sep 19, 24 | Inje University Industry-Academic Cooperation Foundation |
| 2024/0307,341 | Treatment of COVID-19 and Associated Pathologies | Mar 13, 24 | Sep 19, 24 | Chongcha (Fujian) Culture & Technology Co. Ltd. |
Top Owners in This Class
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
Applications Filed in This Class - By Year
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 31 Months (last 2 years Issuances)
- 31 Months (last 5 years Issuances)